Directed Sibling Cord Blood Banking for Transplantation: The 10-Year Experience in the National Blood Service in England

Author:

Smythe Jon1,Armitage Sue2,McDonald Dorothy1,Pamphilon Derwood3,Guttridge Martin1,Brown Juliette4,Green Ann4,Brown Colin4,Warwick Ruth M.5,Lankester Alan1,Fehily Deirdre2,Contreras Marcela6,Navarrete Cristina74,Watt Suzanne M.81

Affiliation:

1. Stem Cells and Immunotherapies Department, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

2. National Health Service Cord Blood Bank, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

3. Bristol Institute of Transfusion Sciences, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

4. Histocompatibility and Immunogenetics Department, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

5. Tissue Services Department, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

6. Division of Diagnostics, Development and Research, National Blood Service, National Health Service Blood and Transplant, United Kingdom

7. Department of Immunology and Molecular Pathology, University College London, London, United Kingdom

8. Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, United Kingdom

Abstract

Abstract Umbilical cord blood (UCB) is an important source of hematopoietic stem cells for transplantation. Although UCB is often collected from unrelated donors, directed umbilical cord blood (DCB) from sibling donors also provides an important source of UCB for transplantation. This report summarizes the experience in collection, testing, storage, and transplantation of DCB units by the National Blood Service for England and North Wales over 10 years. Eligibility for collection was based on an existing sibling suffering from a disease that may be treated by stem cell transplantation or a family history that could result in the birth of a sibling with a disease that could be treated by stem cell transplantation. Collections were made on the provision that the sibling's clinician was willing to financially support the collection and to take responsibility for medical review of the mother and potential recipient. Given the high investment in UCB banking and the introduction of new regulations and mandatory licensing under the European Union Tissues and Cells Directive and those proposed in the U.S., this report details the procedures that we have used for DCB donations, the outcome data where donations have been used for transplantation, and it provides some timely recommendations for best practices. Disclosure of potential conflicts of interest is found at the end of this article.

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3